Otomagnetics, Inc.
ROCKVILLE, MD · CIK 0001711666 · Medtech · Private
Non-invasive magnetic delivery system for therapeutic payloads across biological barriers (blood-labyrinth barrier, eye, skin)
otomagnetics.com →- Grants
- $226K
- 1 award
- Sector median: 1
- Raised
- $1.3M
- 2 Form D · Mar 2018
- 102 months since last filing
- Contracts
- $2.3M
- 1 award · Health and Human S
- #203 of 4531 in medtech
- Patents
- 15
- 1 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Topical Middle Ear Drug Delivery without Tympanic Membrane Puncture | $225,792 | |
| Private capital raised | Form D · SEC | $260,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Drug Delivery System To Save Hearing During Pediatric Chemotherapy Regimens | $2,299,786 | |
| Private capital raised | Form D · SEC | $1,029,014 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 200 | FERRO SOLUTIONS, INC. | $2.3M | — |
| 201 | Simbex LLC | $2.3M | — |
| 202 | ORTHOPEDIATRICS CORP | $2.3M | $39M |
| 203 | Otomagnetics, Inc. | $2.3M | $1.3M |
| 204 | SIGRAY, INC. | $2.3M | — |
| 205 | Molekule Group, Inc. | $2.3M | $25M |
| 206 | ZYMO RESEARCH CORP. | $2.3M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Abhita BatraDirector · Executive Officer
- David BeylinDirector · Executive Officer
- Neela ChipalkattyDirector
- Ting Pau OeiDirector · Executive Officer
- Benjamin ShapiroDirector · Executive Officer
- Irving WeinbergDirector
Patents
- Magnetically-assisted Delivery Into And Through The Skinapplication
- Magnetic Injection Of Therapeutic Agents By Addition Of Material Extrusions With Differing Magnetization And Magnetic Permeabilityapplication
- Medical Cart For Magnetic Treatment Of Middle Ear Conditionsapplication
- Methods And Systems For Shaping Magnetics Fields To Align Forces On Magnetic Particles For Patient Anatomy And Motionapplication
- Magnetically-assisted Delivery Into And Through The Skinapplication
- Magnetically-assisted Delivery Into And Through The Skingranted
- Lipid Coated Iron Oxide Nanoparticles For Otitis Mediaapplication
- Magnetic Nanoparticles For Targeted Deliveryapplication
- Magnetic Nanoparticles For Targeted Deliveryapplication
- Methods And Systems For Shaping Magnetics Fields To Align Forces On Magnetic Particles For Patient Anatomy And Motionapplication
- Medical Cart For Magnetic Treatment Of Middle Ear Conditionsapplication
- Methods and Systems for Shaping Magnetics Fields to Align Forces on Magnetic Particles for Patient Anatomy and Motionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.